Maria de Souza, Cristina <br/><br/>
Thalidomide attenuates mammary cancer associated-inflammation, angiogenesis and tumor growth in mice.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Oct 2012 
 - 491-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2012.04.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Female<br/>Fibroblast Growth Factor 1--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Inflammation--drug therapy<br/>Lung Neoplasms--prevention & control<br/>Macrophages--metabolism<br/>Mammary Neoplasms, Experimental--blood supply<br/>Mice<br/>Mice, Inbred BALB C<br/>Neovascularization, Pathologic--drug therapy<br/>Neutrophils--metabolism<br/>Thalidomide--pharmacology<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Vascular Endothelial Growth Factor A--metabolism